Rescue therapy with tacrolimus and mycophenolate mofetil does not prevent deterioration of graft function in C4d-positive chronic allograft nephropathy
- 1 July 2006
- journal article
- clinical trial
- Published by Springer Nature in Wiener klinische Wochenschrift
- Vol. 118 (13) , 397-404
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Effects of mycophenolate mofetil on donor‐specific antibody formation in renal transplantationClinical Transplantation, 2005
- Risk Factors for Capillary C4d Deposition in Kidney Allografts: Evaluation of a Large Study CohortTransplantation, 2004
- Diagnosis and treatment of antibody-mediated kidney allograft rejectionTransplant International, 2003
- Posttransplantation production of donor HLA-specific antibodies as a predictor of renal transplant outcome1Transplantation, 2003
- Humoral rejection in kidney transplantation: new concepts in diagnosis and treatmentCurrent Opinion in Nephrology and Hypertension, 2002
- All chronic rejection failures of kidney transplants were preceded by the development of HLA antibodiesTransplantation, 2002
- Strategies to Improve Long-Term Outcomes after Renal TransplantationNew England Journal of Medicine, 2002
- Endothelial C4d deposition is associated with inferior kidney allograft outcome independently of cellular rejectionNephrology Dialysis Transplantation, 2001
- Monitoring of anti‐HLA class I and II antibodies by flow cytometry in patients after first cadaveric kidney transplantationClinical Transplantation, 2000
- The Banff 97 working classification of renal allograft pathologyKidney International, 1999